Xenazine Tablet
Product Images NDC 67386-422

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Xenazine (NDC 67386-422). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Lundbeck Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Xenazine Tetrabenazine Tablet 1

Chemical structure of tetrabenazine, the active ingredient in Xenazine. The diagram depicts the molecular configuration including methoxy groups and a ketone functional group.*

FDA Label Image

Xenazine Tetrabenazine Tablet 2

A line graph depicting the change in chorea score over 14 study weeks comparing Xenazine (solid line) with placebo (dashed line). The vertical axis shows chorea score change, and the horizontal axis tracks study weeks. Error bars represent standard error of the mean, and significant differences (p < 0.05) are marked with asterisks. The graph includes a washout period at week 13.*

FDA Label Image

Xenazine Tetrabenazine Tablet 3

A cumulative percentage line graph comparing patients treated with Xenazine and placebo based on changes from baseline in chorea score. The x-axis shows changes in chorea score with markers at -10, -6, and -3 points, while the y-axis shows cumulative percentage of patients up to 100%. The graph includes a table summarizing treatment group percentages achieving specific reductions in chorea score (-10, -6, -3).*

FDA Label Image

Xenazine Tetrabenazine Tablet 4

Packaging label for Xenazine (tetrabenazine) Tablets 12.5 mg, containing 112 tablets, manufactured by Lundbeck Pharmaceuticals LLC. The label includes dosing instructions, storage conditions, and manufacturing information. The product is identified as prescription only and includes barcodes and a note for pharmacists to dispense the accompanying medication guide.*

FDA Label Image

Xenazine Tetrabenazine Tablet 5

Xenazine 25 mg (tetrabenazine) tablets packaging label showing a carton design for 112 tablets. The label indicates oral tablets, manufactured by Recipharm Fontaine SAS and labeled for Lundbeck Pharmaceuticals LLC. It includes storage instructions, manufacturer details, and a note for pharmacists to dispense the medication guide. The label features a white background with blue and green bands and barcodes.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.